BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11737466)

  • 21. Management of vulvar melanoma.
    Trimble EL; Lewis JL; Williams LL; Curtin JP; Chapman D; Woodruff JM; Rubin SC; Hoskins WJ
    Gynecol Oncol; 1992 Jun; 45(3):254-8. PubMed ID: 1612500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic features of vulvar melanoma: a clinicopathologic analysis.
    Johnson TL; Kumar NB; White CD; Morley GW
    Int J Gynecol Pathol; 1986; 5(2):110-8. PubMed ID: 3721696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vulvar/vaginal melanoma: an updated surveillance epidemiology and end results database review, comparison with cutaneous melanoma and significance of racial disparities.
    Mert I; Semaan A; Winer I; Morris RT; Ali-Fehmi R
    Int J Gynecol Cancer; 2013 Jul; 23(6):1118-25. PubMed ID: 23765206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare vulvar malignancies; incidence, treatment and survival in the Netherlands.
    Pleunis N; Schuurman MS; Van Rossum MM; Bulten J; Massuger LF; De Hullu JA; Van der Aa MA
    Gynecol Oncol; 2016 Sep; 142(3):440-5. PubMed ID: 27126004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant melanoma of the vulva. Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients.
    Scheistrøen M; Tropé C; Koern J; Pettersen EO; Abeler VM; Kristensen GB
    Cancer; 1995 Jan; 75(1):72-80. PubMed ID: 7804980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contemporary surgical treatment of advanced-stage melanoma.
    Essner R; Lee JH; Wanek LA; Itakura H; Morton DL
    Arch Surg; 2004 Sep; 139(9):961-6; discussion 966-7. PubMed ID: 15381613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vulvar melanoma: a 33 years single Italian center experience.
    Catalano C; De Magnis A; Kanninen T; Sisti G; Sisti A; Sorbi F; Turrini I; Pimpinelli N; Fambrini M
    G Ital Dermatol Venereol; 2015 Jun; 150(3):277-82. PubMed ID: 25236321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinicopathological study of 30 melanomas of the vulva.
    Tasseron EW; van der Esch EP; Hart AA; Brutel de la Rivière G; Aartsen EJ
    Gynecol Oncol; 1992 Aug; 46(2):170-5. PubMed ID: 1500018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of re-excision of residual adjacent vulvar intraepithelial neoplasia (VIN III) and histological tumour-free margin (hTFM) on survival in primary squamous cell carcinoma of vulva.
    Gasimli K; Straussner M; Schmeil I; Karn T; Winkelmann R; Becker S; El-Balat A
    Arch Gynecol Obstet; 2018 Nov; 298(5):945-950. PubMed ID: 30187190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of an individualized surgical therapy of vulvar carcinoma from 1973-1993].
    Köhler U; Schöne M; Pawlowitsch T
    Zentralbl Gynakol; 1997; 119 Suppl 1():8-16. PubMed ID: 9245126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of treatment, prognostic factors, and survival in 198 vulvar melanoma patients: Implications for clinical practice.
    Boer FL; Ten Eikelder MLG; van Geloven N; Kapiteijn EH; Gaarenstroom KN; Hughes G; Nooij LS; Jozwiak M; Tjiong MY; de Hullu JMA; Galaal K; van Poelgeest MIE
    Gynecol Oncol; 2021 Apr; 161(1):202-210. PubMed ID: 33514483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant vulvo-vaginal melanoma: a report of 7 cases.
    González-Bosquet J; García Jiménez A; Gil Moreno A; Xercavins J
    Eur J Gynaecol Oncol; 1997; 18(1):63-7. PubMed ID: 9061328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for recurrence and survival in primary vulvar squamous cell cancer.
    Ayhan A; Velipasaoglu M; Salman MC; Guven S; Gultekin M; Bayraktar O
    Acta Obstet Gynecol Scand; 2008; 87(11):1143-9. PubMed ID: 18949585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and validation of a prognostic nomogram for primary vulvar melanoma: a SEER population-based study.
    Zhou H; Zou X; Li H; Chen L; Cheng X
    Jpn J Clin Oncol; 2020 Dec; 50(12):1386-1394. PubMed ID: 32776099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic study of 85 cases of melanoma of the female genitalia.
    Tcheung WJ; Selim MA; Herndon JE; Abernethy AP; Nelson KC
    J Am Acad Dermatol; 2012 Oct; 67(4):598-605. PubMed ID: 22243767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center.
    DeMatos P; Tyler D; Seigler HF
    Surgery; 1998 Jul; 124(1):38-48. PubMed ID: 9663250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
    Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
    Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurotropic desmoplastic melanoma: a rare vulvar malignancy.
    Byrne PR; Maiman M; Mikhail A; Harris M; Rosen Y
    Gynecol Oncol; 1995 Feb; 56(2):289-93. PubMed ID: 7896200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant melanoma of the vulva.
    Jaramillo BA; Ganjei P; Averette HE; Sevin BU; Lovecchio JL
    Obstet Gynecol; 1985 Sep; 66(3):398-401. PubMed ID: 4022497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of DNA ploidy and S-phase fraction as prognostic factors in stage III cutaneous melanoma.
    Martin G; Halwani F; Shibata H; Meterissian S
    Can J Surg; 2000 Feb; 43(1):29-34. PubMed ID: 10714254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.